. R-banding revealed that in those metaphases with 46 chromosomes there was a marker chromosome with the long arm of an X and an unidentifiable short arm of dark R-banding material. BudR labelling studies were performed using both cultures derived from the ovaries. The long arm of the marker chromosome was late replicating, suggesting that it was the inactivated X
Pseudotumour cerebri (benign intracranial hypertension) has been reported' in a woman with Turner syndrome (gonadal dysgenesis with X chromosome abnormality) who was mosaic for a cell line containing only one X chromosome and a cell line containing a normal X and an isochromosome for the long arm of X: 45,X/46,X,i(Xq). One of our patients with Turner syndrome and an unusual karyotype also developed pseudotumour cerebri. We question whether the two disorders might be causally related. (table) . R-banding revealed that in those metaphases with 46 chromosomes there was a marker chromosome with the long arm of an X and an unidentifiable short arm of dark R-banding material. BudR labelling studies were performed using both cultures derived from the ovaries. The long arm of the marker chromosome was late replicating, suggesting that it was the inactivated X chromosome. The short arm material, however, appeared not to be late replicating, suggesting derivation from an unidentified autosome. Thus, the patient was mosaic for 164
Pseudotumour cerebri and the Turner syndrome Women with Turner syndrome have gonadal dysgenesis and usually lack ovarian hormone production for which oestrogen and progesterone are taken in physiological replacement doses. They are short and are often obese.7 Therefore, women with Turner syndrome might be expected to be at increased risk for pseudotumour cerebri both because of perturbations in oestrogen/progesterone production and because of obesity. Some individuals with Turner syndrome will spontaneously feminise and/or are fertile; among these women, early menarche, spontaneous pregnancy loss, and chromosomally abnormal offspring are common,8 suggesting that even in this group of patients ovarian function is not normal.
Our single patient with pseudotumour cerebri and Turner syndrome was not receiving exogenous hormones at the time of the onset of the symptoms of increased intracranial pressure. She developed spontaneous menses and menorrhagia at age 14. Her pseudotumour cerebri did not recur at that time, nor at age 15 years when she was begun on thyroid replacement. It is not stated whether the other reported patient' with Turner syndrome was receiving exogenous hormones at the time of her first episode of pseudotumour cerebri. She had had a total abdominal hysterectomy and bilateral salpingo-oophorectomy one year prior to the onset of her signs of increased intracranial pressure. She had not spontaneously feminised and had responded to a trial of oral contraceptives with withdrawal 166 bleeding prior to her hysterectomy. She was obese with a height of 150 cm (<3rd percentile) and a weight of 73 kg (90th percentile).
If Turner syndrome and pseudotumour cerebri are causally linked, the latter should be seen with increased frequency in a Turner syndrome population. Only one of 170 Turner syndrome patients in our clinic had documented pseudotumour cerebri. Papilloedema, visual disturbances and severe headache were not reported in any of the other patients. However, spinal fluid pressures were not obtained, and there remains the possibility that there is an asymptomatic elevation of baseline cerebrospinal fluid pressure in Turner syndrome. We are unaware of any reports in the literature other than that of Donaldson and Binstock.' Among the 14 women with pseudotumour cerebri, all were obese, two had onset of increased intracranial pressure during pregnancy, three had recurrent miscarriages, and four had menstrual irregularities and/or ovarian abnormalities. The number of patients with pseudotumour cerebri that we were able to karyotype is small; while it is possible that one or more of the unkaryotyped individuals has an X chromosome abnormality, this is unlikely. Five have had two or more normal pregnancies and no history of pregnancy loss. None of the unkaryotyped subjects for whom heights were available were less than 156 cm (5'11/2") tall, again making it highly unlikely that they have Turner syndrome.9 The number of patients studied here may be too small to prove or disprove an association between the two disorders. Both pseudotumour cerebri and Turner syndrome are uncommon and a larger population base is needed to establish firmly or to exclude an association.
It is interesting to speculate that women with Sybert, Bird, Salk Turner syndrome may be at increased risk for pseudotumour cerebri because of obesity and hormonal status, rather than because of a primary X chromosome abnormality. Our patient with both disorders had an atypical chromosome constitution as well as evidence for ovarian function. We suggest that the diagnosis of Turner syndrome should be considered and chromosome studies obtained in those women with pseudotumour cerebri who have had multiple pregnancy losses, early menopause, infertility or short stature, as these may be the only indicators of Turner syndrome.4
